During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.58 million, with the beta value of the company hitting 0.62. At the end of the trading day, the stock’s price was $0.75, reflecting an intraday gain of 3.92% or $0.03. The 52-week high for the RLMD share is $4.47, that puts it down -496.0 from that peak though still a striking 68.0% gain since the share price plummeted to a 52-week low of $0.24. The company’s market capitalization is $24.89M, and the average trade volume was 1.81 million shares over the past three months.
Relmada Therapeutics Inc (RLMD) received a consensus recommendation of Sell from analysts. That translates to a mean rating of 3.00. RLMD has a Sell rating from 1 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it.
Relmada Therapeutics Inc (NASDAQ:RLMD) trade information
Relmada Therapeutics Inc (RLMD) registered a 3.92% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.92% in intraday trading to $0.75, hitting a weekly high. The stock’s 5-day price performance is 21.95%, and it has moved by 132.63% in 30 days. Based on these gigs, the overall price performance for the year is -74.58%.
The consensus price target of analysts on Wall Street is $7, which implies an increase of 89.29% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2 and $8 respectively. As a result, RLMD is trading at a discount of -966.67% off the target high and -166.67% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 0.68%. While earnings are projected to return 27.17% in 2025, the next five years will return 31.28% per annum.
RLMD Dividends
Relmada Therapeutics Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 1.23 million shares, is of DEEP TRACK CAPITAL, LP’s that is approximately 16.3686% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $3.7 million.
Also, the Mutual Funds coming in first place with the largest holdings of Relmada Therapeutics Inc (RLMD) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Franklin Strategic Series-FRANKLIN BIOTECHNOLOGY DISCOVERY FUND . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 803.29 shares. This amounts to just over 8.12 percent of the company’s overall shares, with a $0.6 million market value. The same data shows that the other fund manager holds slightly less at 456.4, or about 4.61% of the stock, which is worth about $0.34 million.
